Beta-2 microglobulin as a marker of renal lesions in rheumatoid arthritis.

Abstract

Over the last years, a growth of the renal morbidity has been observed in patients with rheumatoid arthritis, a need of elaborating approaches to an early diagnosis of these abnormalities has arisen. A lot of studies to date have demonstrated large correlations between measures of renal function and suitable serum levels of beta-2 microglobulin. The aim of the study. To study beta-2 microglobulin and to detect renal complications in patients with rheumatoid arthritis at early stages.